Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Market Cap	7.35B
Revenue (ttm)	33.60B
Net Income (ttm)	675.86M
Shares Out	n/a
EPS (ttm)	0.18
PE Ratio	10.88
Forward PE	12.24
Dividend	0.05 (3.97%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	170
Open	1.240
Previous Close	1.230
Day's Range	1.240 - 1.240
52-Week Range	1.160 - 1.550
Beta	n/a
RSI	49.91
Earnings Date	Mar 31, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 49,402
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S1R

Financial Performance

In 2024, FRA:S1R's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY